phenytoin has been researched along with Malignant Melanoma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 29-year-old white man with brain metastases secondary to malignant melanoma consistently had suboptimal phenytoin concentrations while receiving chemotherapy consisting of cisplatin, carmustine, dacarbazine, and tamoxifen." | 4.79 | Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review. ( Gattis, WA; May, DB, 1996) |
| "The DNS II acetone fraction of Delphinium nordhagenii has exhibited the anticonvulsant actions by preventing the seizures against PTZ- and picrotoxin-induced seizure as well as 100% seizure protection in MES test." | 3.76 | Anticonvulsant activity of DNS II fraction in the acute seizure models. ( Ahmad, M; Raza, ML; Shaheen, F; Simjee, SU; Zeeshan, M, 2010) |
| "The effects of a single Phenytoin dose, given to patients with malignant melanoma, upon peripheral blood counts, serum immunoglobulins, lymphocyte subpopulations and lymphocytotoxicity (using Chang target cells) were recorded." | 3.66 | Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients. ( Crowther, D; Swindell, R; Thatcher, N; Wan, HH; Wilkinson, PM, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raza, ML | 1 |
| Zeeshan, M | 1 |
| Ahmad, M | 1 |
| Shaheen, F | 1 |
| Simjee, SU | 1 |
| Thatcher, N | 2 |
| Wan, HH | 2 |
| Swindell, R | 1 |
| Wilkinson, PM | 2 |
| Crowther, D | 1 |
| Gattis, WA | 1 |
| May, DB | 1 |
| Mullen, PW | 1 |
| Smith, GN | 1 |
| Ghosh, C | 1 |
| Lazarus, HM | 1 |
| Hewlett, JS | 1 |
| Creger, RJ | 1 |
| Dorfman, RF | 1 |
| Warnke, R | 1 |
2 reviews available for phenytoin and Malignant Melanoma
| Article | Year |
|---|---|
Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review.
Topics: Adult; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Dexamethasone; Drug Interactions; Hu | 1996 |
Lymphadenopathy simulating the malignant lymphomas.
Topics: Animals; Biopsy; Dermatitis; Drug Hypersensitivity; Herpes Zoster; Humans; Hyalin; Hyperplasia; Infe | 1974 |
1 trial available for phenytoin and Malignant Melanoma
| Article | Year |
|---|---|
Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.
Topics: Adult; Anticonvulsants; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carbamazepine; Fe | 1992 |
4 other studies available for phenytoin and Malignant Melanoma
| Article | Year |
|---|---|
Anticonvulsant activity of DNS II fraction in the acute seizure models.
Topics: Acetone; Animals; Anticonvulsants; Delphinium; Diazepam; Epilepsy; Male; Melanoma; Mice; Mice, Inbre | 2010 |
Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.
Topics: Bacterial Vaccines; Cytotoxicity, Immunologic; Female; Humans; Immunoglobulin G; Immunotherapy; Kill | 1982 |
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.
Topics: Adenocarcinoma; Adult; Aged; Bacterial Vaccines; BCG Vaccine; Female; Humans; Immunotherapy; Kidney | 1979 |
Immune mechanisms in cancer.
Topics: Animals; Antibodies, Neoplasm; Antigen-Antibody Complex; Antigens, Neoplasm; Humans; Immunity, Cellu | 1973 |